Improving hidradenitis suppurativa management: consensus statements from physicians and patients' perspectives

Arch Dermatol Res. 2024 Aug 24;316(8):577. doi: 10.1007/s00403-024-03316-2.

Abstract

Hidradenitis suppurativa (HS) is a frequent chronic inflammatory skin condition primarily affecting areas rich in apocrine sweat glands, presenting with comedones, papules, nodules, and abscesses, as well as tunnels and hypertrophic scarring. Despite its prevalence and impact on quality of life, the pathogenesis of HS remains incompletely understood. Notably, its diagnosis often suffers from delays and misidentification, therefore an improved education for healthcare providers is mandatory. Moreover, HS is frequently associated with systemic comorbidities and a multidisciplinary approach is suggested for its management. Recognizing these challenges, a group of Italian HS experts and patients convened to develop consensus guidelines via the Nominal Group Technique. Through iterative meetings and remote collaboration, they identified key areas for improvement and formulated consensus statements to guide healthcare providers in delivering optimal care. This collaborative effort highlights the importance of standardized approaches and interdisciplinary collaboration in managing HS effectively.

Keywords: Biologics; HS-unit; Multidisciplinary approach; Patient’s journey; Quality of life.

Publication types

  • Review

MeSH terms

  • Consensus*
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / therapy
  • Humans
  • Italy
  • Quality of Life